Epigenetic silencing of the tumor suppressor genes SPI1, PRDX2, KLF4, DLEC1, and DAPK1 in childhood and adolescent lymphomas

Pediatric Hematology and Oncology
İhsan ÖzdemirCeyda Karadeniz

Abstract

The aim of the study was to investigate the expression and methylation status of seven distinctive genes with tumor suppressing properties in childhood and adolescent lymphomas. A total of 96 patients with Hodgkin Lymphoma (HL, n = 41), Non-Hodgkin Lymphoma (NHL, n = 15), and reactive lymphoid hyperplasia (RLH, n = 40, as controls) are included in the research. The expression status of CDKN2A, SPI1, PRDX2, DLEC1, FOXO1, KLF4 and DAPK1 genes were measured with QPCR method after the RNA isolation from paraffin blocks of tumor tissue and cDNA conversion. DNA isolation was performed from samples with low gene expression followed by methylation PCR study specific to promoter regions of these genes. We found that SPI1, PRDX2, DLEC1, KLF4, and DAPK1 genes are significantly less expressed in patient than the control group (p = 0.0001). However, expression of CDKNA2 and FOXO1 genes in the patient and control groups were not statistically different. The methylation ratios of all genes excluding the CDKN2A and FOXO1 were significantly higher in the HL and NHL groups than the controls (p = 0.0001). We showed that SPI1, PRDX2, DLEC1, KLF4 and DAPK1 genes are epigenetically silenced via hypermethylation in the tumor tissues of children with ...Continue Reading

References

Jul 13, 2002·Trends in Biochemical Sciences·Boudewijn M T Burgering, Geert J P L Kops
Aug 13, 2002·Cancer Biology & Therapy·Shujuan J XiaFrederic G Barr
Aug 23, 2002·Seminars in Cancer Biology·Mikael S Lindström, Klas G Wiman
Jul 23, 2003·Journal of the American Society of Nephrology : JASN·Sue Goo RheeSang Won Kang
Nov 25, 2003·The New England Journal of Medicine·James G Herman, Stephen B Baylin
Aug 5, 2006·Pharmacogenomics·Justin StebbingTim Crook
Apr 1, 2008·International Immunology·Isharat YusufDavid A Fruman
Apr 9, 2008·Oncogene·Z Fu, D J Tindall
May 30, 2009·The FEBS Journal·Andrea HallLeslie B Poole
Nov 3, 2009·Cell·Lakshmi SrinivasanKlaus Rajewsky
Jan 21, 2011·Cellular and Molecular Life Sciences : CMLS·Maria Hatziapostolou, Dimitrios Iliopoulos
Feb 22, 2012·Blood·Linka XieThomas Wirth
Jul 10, 2012·Cell·Mark A Dawson, Tony Kouzarides
Jul 14, 2012·Cancer Cell·Jueng Soo You, Peter A Jones
Mar 20, 2013·Seminars in Hematology·Kristen H TaylorCharles W Caldwell
Sep 27, 2013·Leukemia & Lymphoma·Alberto Valencia-HipόlitoMario I Vega
Nov 13, 2013·Apoptosis : an International Journal on Programmed Cell Death·Natalya Benderska, Regine Schneider-Stock
Nov 14, 2013·Apoptosis : an International Journal on Programmed Cell Death·Shani Bialik, Adi Kimchi
May 13, 2014·The Journal of Molecular Diagnostics : JMD·Manuela GiacheliaStefan Hohaus
May 13, 2014·Clinical and Translational Science·Milena KrajnovićKoviljka Krtolica
Jul 5, 2015·Current Oncology Reports·Jennifer K LueOwen A O'Connor
Sep 10, 2015·Cellular Oncology (Dordrecht)·Myriam Ben DhiabMounir Trimeche
Dec 5, 2015·Oncotarget·Anna TrzecieckaMalgorzata Firczuk
Dec 22, 2015·Cellular and Molecular Life Sciences : CMLS·Alexandra Coomans de Brachène, Jean-Baptiste Demoulin
Sep 10, 2016·Clinical Epigenetics·Lasse Sommer KristensenKirsten Grønbæk
Oct 21, 2016·Leukemia & Lymphoma·Marcin BraunUNKNOWN Polish Pediatric Leukemia/Lymphoma Study Group
Feb 27, 2017·Gene·Amr M Ghaleb, Vincent W Yang
Mar 11, 2017·Leukemia & Lymphoma·Xin-Yu LiXin Wang
Mar 31, 2017·Molecular and Clinical Oncology·Arianna NicolussiAnna Coppa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.